{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T14:01:50Z","timestamp":1793109710433,"version":"4.5.0"},"reference-count":56,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T00:00:00Z","timestamp":1750118400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82271794"],"award-info":[{"award-number":["82271794"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82302533"],"award-info":[{"award-number":["82302533"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82101852"],"award-info":[{"award-number":["82101852"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plospathogens.org"],"crossmark-restriction":false},"short-container-title":["PLoS Pathog"],"abstract":"<jats:p>Despite the therapeutic benefit of immune checkpoint blockade in cancers, there is no consensus on its effect in infectious diseases. Here we investigated whether blocking the immune checkpoint T cell immunoreceptor with immunoglobulin and immunoreceptor tyrosine-based inhibitory motif domains (TIGIT) increases T cell immunity in active <jats:italic>Mycobacterium tuberculosis<\/jats:italic> infection. TIGIT expression in both peripheral blood and lung lesions in tuberculosis patients was assessed, and the correlation with clinical features analyzed. The functional status of TIGIT<jats:sup>+<\/jats:sup> and TIGIT<jats:sup>\u2212<\/jats:sup>CD8<jats:sup>+<\/jats:sup> T cell subsets in tuberculosis patients was analyzed by flow cytometry and transcriptome analysis. To investigate the regulatory effect of TIGIT, the function of CD8<jats:sup>+<\/jats:sup> T cells in tuberculosis patients and bacterial load in a tuberculosis mouse model were assessed after <jats:italic>in vitro<\/jats:italic> and <jats:italic>in vivo<\/jats:italic> TIGIT blockade. In active tuberculosis patients, TIGIT expression on CD8<jats:sup>+<\/jats:sup> T cells in the peripheral blood was significantly upregulated and positively correlated with disease severity. TIGIT expression in lung lesions was significantly higher in patients with pulmonary tuberculosis than in patients infected with other pathogens. TIGIT<jats:sup>+<\/jats:sup>CD8<jats:sup>+<\/jats:sup> T cells exhibited higher activation and differentiation levels, increased expression levels of cytokines and cytotoxic molecules, and showed gene expression features of natural killer-like cytotoxic effector CD8<jats:sup>+<\/jats:sup> T cells. TIGIT blockade increased the ability of human CD8<jats:sup>+<\/jats:sup> T cells to produce effector molecules and kill intracellular bacteria <jats:italic>in vitro<\/jats:italic>. Importantly, blocking TIGIT reduced lung bacterial burden in mice infected with <jats:italic>M. tuberculosis<\/jats:italic>. The findings reveal that in active tuberculosis patients, activated CD8<jats:sup>+<\/jats:sup> T cells express TIGIT and blocking TIGIT enhances CD8<jats:sup>+<\/jats:sup> T cell function and promotes clearance of <jats:italic>M. tuberculosis<\/jats:italic>. The findings also suggest that TIGIT limits T cell immunity in tuberculosis and implicate TIGIT blockade as a novel strategy for tuberculosis therapy.<\/jats:p>","DOI":"10.1371\/journal.ppat.1013228","type":"journal-article","created":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T17:41:12Z","timestamp":1750182072000},"page":"e1013228","update-policy":"https:\/\/doi.org\/10.1371\/journal.ppat.corrections_policy","source":"Crossref","is-referenced-by-count":4,"title":["TIGIT blockade improves anti-Mycobacterium tuberculosis immunity"],"prefix":"10.1371","volume":"21","author":[{"given":"Jingyu","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingluan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoxin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huaxin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinfang","family":"Ou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengqing","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixuan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feiran","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuzhen","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianqian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingyun","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4931-3510","authenticated-orcid":true,"given":"Qiaoling","family":"Ruan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2025,6,17]]},"reference":[{"key":"ppat.1013228.ref001","year":"2024"},{"issue":"3","key":"ppat.1013228.ref002","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00655-2019","article-title":"The global prevalence of latent tuberculosis: a systematic review and meta-analysis","volume":"54","author":"A Cohen","year":"2019","journal-title":"Eur Respir J"},{"issue":"9","key":"ppat.1013228.ref003","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/s41577-018-0025-3","article-title":"Immunological mechanisms of human resistance to persistent Mycobacterium tuberculosis infection","volume":"18","author":"JD Simmons","year":"2018","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"ppat.1013228.ref004","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/35095558","article-title":"How can immunology contribute to the control of tuberculosis?","volume":"1","author":"SH Kaufmann","year":"2001","journal-title":"Nat Rev Immunol"},{"issue":"3","key":"ppat.1013228.ref005","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s00281-015-0490-8","article-title":"CD8 T cells and Mycobacterium tuberculosis infection","volume":"37","author":"PL Lin","year":"2015","journal-title":"Semin Immunopathol"},{"key":"ppat.1013228.ref006","doi-asserted-by":"crossref","first-page":"102567","DOI":"10.1016\/j.tube.2024.102567","article-title":"Tuberculosis and T cells: impact of T cell diversity in tuberculosis infection","volume":"149","author":"D Vats","year":"2024","journal-title":"Tuberculosis (Edinb)"},{"issue":"12","key":"ppat.1013228.ref007","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20230707","article-title":"CD8 lymphocytes are critical for early control of tuberculosis in macaques","volume":"220","author":"CG Winchell","year":"2023","journal-title":"J Exp Med"},{"issue":"5","key":"ppat.1013228.ref008","doi-asserted-by":"crossref","DOI":"10.1016\/j.immuni.2022.04.004","article-title":"Multimodal profiling of lung granulomas in macaques reveals cellular correlates of tuberculosis control","volume":"55","author":"HP Gideon","year":"2022","journal-title":"Immunity"},{"issue":"7788","key":"ppat.1013228.ref009","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/s41586-019-1817-8","article-title":"Prevention of tuberculosis in macaques after intravenous BCG immunization","volume":"577","author":"PA Darrah","year":"2020","journal-title":"Nature"},{"issue":"8","key":"ppat.1013228.ref010","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/nri3862","article-title":"Molecular and cellular insights into T cell exhaustion","volume":"15","author":"EJ Wherry","year":"2015","journal-title":"Nat Rev Immunol"},{"issue":"11","key":"ppat.1013228.ref011","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1038\/s41590-019-0512-0","article-title":"Inhibitory receptors and ligands beyond PD-1, PD-L1 and CTLA-4: breakthroughs or backups","volume":"20","author":"LP Andrews","year":"2019","journal-title":"Nat Immunol"},{"issue":"2","key":"ppat.1013228.ref012","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/nri.2017.112","article-title":"Immune checkpoint blockade in infectious diseases","volume":"18","author":"MN Wykes","year":"2018","journal-title":"Nat Rev Immunol"},{"issue":"5","key":"ppat.1013228.ref013","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02512-2021","article-title":"The paradox of immune checkpoint inhibition re-activating tuberculosis","volume":"60","author":"M Ahmed","year":"2022","journal-title":"Eur Respir J"},{"issue":"4","key":"ppat.1013228.ref014","doi-asserted-by":"crossref","DOI":"10.1136\/esmoopen-2020-000866","article-title":"Mycobacterial infections due to PD-1 and PD-L1 checkpoint inhibitors","volume":"5","author":"K Anand","year":"2020","journal-title":"ESMO Open"},{"issue":"2","key":"ppat.1013228.ref015","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/cei.13407","article-title":"TIGIT as an emerging immune checkpoint","volume":"200","author":"H Harjunpaa","year":"2020","journal-title":"Clin Exp Immunol"},{"issue":"6","key":"ppat.1013228.ref016","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.ccell.2014.10.018","article-title":"The immunoreceptor TIGIT regulates antitumor and antiviral CD8(+) T cell effector function","volume":"26","author":"RJ Johnston","year":"2014","journal-title":"Cancer Cell"},{"issue":"12","key":"ppat.1013228.ref017","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1111\/jvh.12465","article-title":"Memory re-differentiation and reduced lymphocyte activation in chronic HCV-infected patients receiving direct-acting antivirals","volume":"22","author":"MA Burchill","year":"2015","journal-title":"J Viral Hepat"},{"issue":"1","key":"ppat.1013228.ref018","article-title":"TIGIT marks exhausted T Cells, correlates with disease progression, and serves as a target for immune restoration in HIV and SIV infection","volume":"12","author":"GM Chew","year":"2016","journal-title":"PLoS Pathog"},{"issue":"4","key":"ppat.1013228.ref019","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1002\/hep.30896","article-title":"Immune exhaustion of T Cells in alveolar echinococcosis patients and its reversal by blocking checkpoint receptor TIGIT in a murine model","volume":"71","author":"C Zhang","year":"2020","journal-title":"Hepatology"},{"key":"ppat.1013228.ref020","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1051\/parasite\/2021010","article-title":"Expression of TIGIT in splenic and circulatory T cells from mice acutely infected with Toxoplasma gondii","volume":"28","author":"S Wang","year":"2021","journal-title":"Parasite"},{"key":"ppat.1013228.ref021","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3389\/fcimb.2020.00175","article-title":"TIGIT blockade: a multipronged approach to target the HIV reservoir","volume":"10","author":"KA Holder","year":"2020","journal-title":"Front Cell Infect Microbiol"},{"issue":"2","key":"ppat.1013228.ref022","article-title":"TIGIT in cancer immunotherapy","volume":"8","author":"J-M Chauvin","year":"2020","journal-title":"J Immunother Cancer"},{"issue":"12","key":"ppat.1013228.ref023","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1038\/ni1268","article-title":"Effector and memory CD8+ T cell fate coupled by T-bet and eomesodermin","volume":"6","author":"AM Intlekofer","year":"2005","journal-title":"Nat Immunol"},{"issue":"4","key":"ppat.1013228.ref024","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-004711","article-title":"TIGIT-CD226-PVR axis: advancing immune checkpoint blockade for cancer immunotherapy","volume":"10","author":"EY Chiang","year":"2022","journal-title":"J Immunother Cancer"},{"key":"ppat.1013228.ref025","doi-asserted-by":"crossref","first-page":"110358","DOI":"10.1016\/j.intimp.2023.110358","article-title":"TIGIT: An emerging immune checkpoint target for immunotherapy in autoimmune disease and cancer","volume":"120","author":"J Zhao","year":"2023","journal-title":"Int Immunopharmacol"},{"issue":"6","key":"ppat.1013228.ref026","first-page":"375","article-title":"Progress in T-cell immunoglobulin and immunoreceptor tyrosine-based inhibitory motif domain-mediated T-cell exhaustion in chronic infection","volume":"39","author":"J Zhou","year":"2021","journal-title":"Zhonghua Chuan Ran Bing Za Zhi"},{"key":"ppat.1013228.ref027","doi-asserted-by":"crossref","first-page":"120","DOI":"10.3389\/fcimb.2020.00120","article-title":"Distinct human NK cell phenotypes and functional responses to mycobacterium tuberculosis in adults from TB endemic and non-endemic regions","volume":"10","author":"LD Harris","year":"2020","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"ppat.1013228.ref028","doi-asserted-by":"crossref","first-page":"175","DOI":"10.4049\/jimmunol.2100073","article-title":"Pre-existing simian immunodeficiency virus infection increases expression of T cell markers associated with activation during early mycobacterium tuberculosis coinfection and impairs TNF responses in granulomas","volume":"207","author":"EC Larson","year":"2021","journal-title":"J Immunol"},{"key":"ppat.1013228.ref029","first-page":"670","article-title":"Expression of immunosuppressive receptor T cell immunoglobulin and immunoreceptor tyrosine-based inhibitory motif domain on CD8 T cells in silicosis patients with Mycobacterium tuberculosis infection","volume":"11","author":"X Yuzhen","year":"2021","journal-title":"Zhonghua Chuan Ran Bing Za Zhi"},{"key":"ppat.1013228.ref030","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.3389\/fimmu.2018.02755","article-title":"The roles of coinhibitory receptors in pathogenesis of human retroviral infections","volume":"9","author":"K Yasuma-Mitobe","year":"2018","journal-title":"Front Immunol"},{"key":"ppat.1013228.ref031","doi-asserted-by":"crossref","first-page":"108205","DOI":"10.1016\/j.intimp.2021.108205","article-title":"Immune checkpoint molecule TIGIT manipulates T cell dysfunction in septic patients","volume":"101","author":"Y Sun","year":"2021","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"ppat.1013228.ref032","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1038\/s41467-020-15025-1","article-title":"TIGIT limits immune pathology during viral infections","volume":"11","author":"M Schorer","year":"2020","journal-title":"Nat Commun"},{"issue":"3","key":"ppat.1013228.ref033","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1002\/JLB.MA1118-450RR","article-title":"PD-1 modulating Mycobacterium tuberculosis-specific polarized effector memory T cells response in tuberculosis pleurisy","volume":"106","author":"J Li","year":"2019","journal-title":"J Leukoc Biol"},{"issue":"11","key":"ppat.1013228.ref034","article-title":"Tim-3-expressing CD4+ and CD8+ T cells in human tuberculosis (TB) exhibit polarized effector memory phenotypes and stronger anti-TB effector functions","volume":"8","author":"Y Qiu","year":"2012","journal-title":"PLoS Pathog"},{"key":"ppat.1013228.ref035","doi-asserted-by":"crossref","first-page":"5160565","DOI":"10.1155\/2019\/5160565","article-title":"Patterns of TIGIT expression in lymphatic tissue, inflammation, and cancer","volume":"2019","author":"NC Blessin","year":"2019","journal-title":"Dis Markers"},{"issue":"3","key":"ppat.1013228.ref036","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.01724-21","article-title":"Spontaneous control of SIV replication does not prevent T cell dysregulation and bacterial dissemination in animals co-infected with M. tuberculosis","volume":"10","author":"RV Moriarty","year":"2022","journal-title":"Microbiol Spectr"},{"issue":"5","key":"ppat.1013228.ref037","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1008585","article-title":"MAIT cells are functionally impaired in a Mauritian cynomolgus macaque model of SIV and Mtb co-infection","volume":"16","author":"AL Ellis","year":"2020","journal-title":"PLoS Pathog"},{"issue":"2","key":"ppat.1013228.ref038","first-page":"136","article-title":"Study on role of TIGIT signal in Th1\/Th2 balance in Schistosoma japonicum-infected mice","volume":"30","author":"Z Li-Na","year":"2018","journal-title":"Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi"},{"issue":"6","key":"ppat.1013228.ref039","doi-asserted-by":"crossref","first-page":"3376","DOI":"10.1002\/hep.32035","article-title":"Involvement of TIGIT in natural killer cell exhaustion and immune escape in patients and mouse model with liver echinococcus multilocularis infection","volume":"74","author":"C Zhang","year":"2021","journal-title":"Hepatology"},{"issue":"2","key":"ppat.1013228.ref040","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/cei.13544","article-title":"Th22 response induced by Mycobacterium tuberculosis strains is closely related to severity of pulmonary lesions and bacillary load in patients with multi-drug-resistant tuberculosis","volume":"203","author":"BR Imperiale","year":"2021","journal-title":"Clin Exp Immunol"},{"issue":"4","key":"ppat.1013228.ref041","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.jinf.2011.02.013","article-title":"Elevated expression of Tim-3 on CD8 T cells correlates with disease severity of pulmonary tuberculosis","volume":"62","author":"X Wang","year":"2011","journal-title":"J Infect"},{"issue":"1","key":"ppat.1013228.ref042","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/ni.1674","article-title":"The surface protein TIGIT suppresses T cell activation by promoting the generation of mature immunoregulatory dendritic cells","volume":"10","author":"X Yu","year":"2009","journal-title":"Nat Immunol"},{"key":"ppat.1013228.ref043","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1146\/annurev-immunol-041015-055318","article-title":"CD8 T cell exhaustion during chronic viral infection and cancer","volume":"37","author":"LM McLane","year":"2019","journal-title":"Annu Rev Immunol"},{"issue":"5","key":"ppat.1013228.ref044","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.immuni.2016.05.001","article-title":"Lag-3, Tim-3, and TIGIT: co-inhibitory receptors with specialized functions in immune regulation","volume":"44","author":"AC Anderson","year":"2016","journal-title":"Immunity"},{"key":"ppat.1013228.ref045","doi-asserted-by":"crossref","first-page":"40354","DOI":"10.1038\/srep40354","article-title":"Perturbed CD8+ T cell TIGIT\/CD226\/PVR axis despite early initiation of antiretroviral treatment in HIV infected individuals","volume":"7","author":"J Tauriainen","year":"2017","journal-title":"Sci Rep"},{"issue":"9","key":"ppat.1013228.ref046","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1093\/infdis\/jiab155","article-title":"Correlation between TIGIT expression on CD8+ T cells and higher cytotoxic capacity","volume":"224","author":"J Blazkova","year":"2021","journal-title":"J Infect Dis"},{"issue":"3","key":"ppat.1013228.ref047","article-title":"KIR(+)CD8(+) and NKG2A(+)CD8(+) T cells are distinct innate-like populations in humans","volume":"42","author":"SJ Choi","year":"2023","journal-title":"Cell Rep"},{"issue":"3","key":"ppat.1013228.ref048","article-title":"Inhibition of hepatic natural killer cell function via the TIGIT receptor in schistosomiasis-induced liver fibrosis","volume":"19","author":"Y Gao","year":"2023","journal-title":"PLoS Pathog"},{"issue":"9","key":"ppat.1013228.ref049","article-title":"Low levels of T cell exhaustion in tuberculous lung granulomas","volume":"86","author":"EA Wong","year":"2018","journal-title":"Infect Immun"},{"issue":"30","key":"ppat.1013228.ref050","doi-asserted-by":"crossref","first-page":"13402","DOI":"10.1073\/pnas.1007394107","article-title":"Programmed death-1 (PD-1)-deficient mice are extraordinarily sensitive to tuberculosis","volume":"107","author":"E L\u00e1z\u00e1r-Moln\u00e1r","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"ppat.1013228.ref051","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0019864","article-title":"T cells from Programmed Death-1 deficient mice respond poorly to Mycobacterium tuberculosis infection","volume":"6","author":"S Tousif","year":"2011","journal-title":"PLoS One"},{"issue":"3","key":"ppat.1013228.ref052","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.4049\/jimmunol.1003304","article-title":"CD4 T cells promote rather than control tuberculosis in the absence of PD-1-mediated inhibition","volume":"186","author":"DL Barber","year":"2011","journal-title":"J Immunol"},{"issue":"55","key":"ppat.1013228.ref053","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abf3861","article-title":"PD-1 blockade exacerbates Mycobacterium tuberculosis infection in rhesus macaques","volume":"6","author":"KD Kauffman","year":"2021","journal-title":"Sci Immunol"},{"issue":"475","key":"ppat.1013228.ref054","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aat2702","article-title":"Tuberculosis following PD-1 blockade for cancer immunotherapy","volume":"11","author":"DL Barber","year":"2019","journal-title":"Sci Transl Med"},{"issue":"6","key":"ppat.1013228.ref055","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.bjid.2018.10.280","article-title":"Assessing and screening for T-cell epitopes from Mycobacterium tuberculosis RD2 proteins for the diagnosis of active tuberculosis","volume":"22","author":"J Chen","year":"2018","journal-title":"Braz J Infect Dis"},{"issue":"7","key":"ppat.1013228.ref056","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1010721","article-title":"IFN-\u03b3-independent control of M. tuberculosis requires CD4 T cell-derived GM-CSF and activation of HIF-1\u03b1","volume":"18","author":"E Van Dis","year":"2022","journal-title":"PLoS Pathog"}],"container-title":["PLOS Pathogens"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.ppat.1013228","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T17:41:28Z","timestamp":1750182088000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.ppat.1013228"}},"subtitle":[],"editor":[{"given":"David M.","family":"Lewinsohn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,6,17]]},"references-count":56,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,6,17]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.ppat.1013228","relation":{},"ISSN":["1553-7374"],"issn-type":[{"value":"1553-7374","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,17]]}}}